首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Note: Comparative Bacteriostatic and Bactericidal Activities of Cefodizime against Borrelia burgdorferi Sensu Lato
【2h】

Note: Comparative Bacteriostatic and Bactericidal Activities of Cefodizime against Borrelia burgdorferi Sensu Lato

机译:注意:头孢地嗪对伯氏疏螺旋体的抑菌和杀菌活性比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The MIC and MSC (minimum spirocheticidal concentration) and killing rate for Borrelia burgdorferi, the etiological agent of Lyme disease, were assessed for cefodizime in comparison with ceftriaxone, minocycline, azithromycin, roxithromycin, and ciprofloxacin. The range of cefodizime MICs was greater than those of azithromycin and roxithromycin but comparable to those of ceftriaxone and minocycline. The MSCs were 1 to 2 dilutions higher than the MICs of all of the tested compounds. The killing curves of cefodizime and ceftriaxone showed parallel courses. In conclusion, cefodizime exerted an activity comparable to that of ceftriaxone against B. burgdorferi.
机译:与头孢曲松,米诺环素,阿奇霉素,罗红霉素和环丙沙星相比,对莱姆病的病原体伯氏疏螺旋体的MIC和MSC(最小杀线虫浓度)和杀灭率进行了评估。头孢地嗪MIC的范围大于阿奇霉素和罗红霉素的范围,但与头孢曲松和米诺环素相当。 MSC比所有测试化合物的MIC高1-2倍。头孢地嗪和头孢曲松的杀伤曲线呈平行变化。总之,头孢地嗪对伯氏疏螺旋体的活性与头孢曲松相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号